Patent · US Active

Methods for diagnosing hematological cancers

US10969391B2 · kind B2 · utility

3Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 10, 2015
Grant dateApr 6, 2021
Priority date
Expiry dateDec 8, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to methods for diagnosing hematological cancers. In particular, the present invention relates to a method for diagnosing a hematological cancer in a patient comprising i) detecting the presence of CD45RARO NK cells in a sample obtained from the patient and ii) and concluding that the patient suffers from a hematological cancer when the presence of CD45RARO NK cells is detected in the sample and the presence of at least one phenotypic marker indicates the nature of the haematological cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.